A study on the Tregs in the tumor environment found that miR-125b-5p targets TNFR2 and reduces Treg proliferation along with their immunosuppressive function, leading to enhanced anti-tumor immunity [126]. The gene discussed is TNFRSF1B; the disease is neoplasm.